India Vaccine

Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.

Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.

The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

After the success of the Co-WIN platform, the government has now replicated it to set up an electronic registry for routine vaccinations.

Norovirus infection is again making headlines after local news outlets reported that the virus has been reported in some schools in Kerala's Ernakulam district.

The Congress on Sunday accused Union minister Rajeev Chandrasekhar of distorting facts and indulging in "false propaganda" by alleging that the leaders of the opposition party were pushing the case of foreign Covid vaccines.

iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.

Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.

Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.

Mansukh Manadaviya said that the world's first intranasal vaccine for Covid-19 iNCOVACC launched is a testimony to the innovative zeal of our scientists and a display of India's research and innovation prowess under the leadership of PM Modi.

The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.

A day after the first indigenously developed Human Papillomavirus vaccine against cervical cancer was launched, Serum Institute of India CEO Adar Poonawalla on Wednesday said the vaccine will be available in small quantity this year.

China needs a good COVID-19 booster vaccine like Covovax, but so far there hasn't been a positive response from China, said Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday.

Dr Raman Gangakhedkar, former head of epidemiology and communicable diseases at the Indian Council of Medical Research, has discounted the need for the fourth dose of COVID-19 vaccine given the current evidence about the coronavirus and its variants.

After the success of the Co-WIN platform, the government has now replicated it to set up an electronic registry for routine vaccinations.

Norovirus infection is again making headlines after local news outlets reported that the virus has been reported in some schools in Kerala's Ernakulam district.

The Congress on Sunday accused Union minister Rajeev Chandrasekhar of distorting facts and indulging in "false propaganda" by alleging that the leaders of the opposition party were pushing the case of foreign Covid vaccines.

iNCOVACC, the world's first COVID-19 intranasal vaccine, will be launched on January 26. The intranasal coronavirus vaccine has been developed by India's Bharat Biotech.

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26.

Vaccine maker Serum Institute of India CEO Adar Poonawalla has called for global harmonisation or regulatory standards and said that cooperation among multilateral organisations is a must for dealing with future outbreaks.

Serum Institute of India has written to the Union Health Ministry seeking the inclusion of its Covid vaccine Covovax in the CoWIN portal as a heterologous booster dose for adults, official sources said on Wednesday.

The Serum Institute of India is working to market its two key vaccines for Covid -- Covovax and Covishield -- in China, which is seeing a resurgence of the pandemic.

The Union Health Ministry said media reports claiming admission of 'multiple side-effects of COVID-19 vaccines' by Indian Council of Medical Research (ICMR) and Central Drugs Standard Control Organisation (CDSCO) officials are ill-informed.